About
Technology
Issues
FAQ
Links
Official Page
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.